Intrinsic Value of S&P & Nasdaq Contact Us

Protagenic Therapeutics, Inc. PTIXW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
11/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — PTIXW

Protagenic Therapeutics, Inc. (PTIXW) has a market capitalization of $27.16K and trades at $0.02. The 52-week range is 0.015-0.026.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-3.45.

The stock has a beta of 0.47, operates in the Healthcare sector.

Trading Data
Current Price$0.02
52-Week Range0.015-0.026
Volume24.02K
Avg Volume (30D)42.14K
Market Cap$27.16K
Beta (1Y)0.47
Company
IPO Date2021-04-27
Employees1
CEOGaro H. Armen
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS74365N1110
CUSIP74365N111
Income (Latest Year)
Gross Profit$-37.72K
EBITDA$-8.02M
Operating Income$-5.83M
Net Income$-5.16M
EPS$-3.45
EPS Diluted$-3.45
Shares Outstanding$1.93M
Balance Sheet (Latest Year)
Total Assets$2.13M
Current Assets$2.3M
Cash & ST Investments$2.21M
Total Liabilities$6.82M
Total Debt$3.16M
Net Debt$943.26K
Total Equity$-4.69M
Debt / Equity-0.67
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message